# Tislelizumab Plus Chemotherapy vs Chemotherapy Alone as First-line Treatment for Advanced Squamous Non–Small-Cell Lung Cancer

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/tislelizumab-plus-chemotherapy-vs-chemotherapy-alone-as-first-line-treatment-for/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Jie Wang,Shun Lü,Xinmin Yu,Yanping Hu,Yuping Sun,Zhijie Wang,Jun Zhao,Yan Yu,Chunhong Hu,Kunyu Yang,Guosheng Feng,Kejing Ying,Wu Zhuang,Jianying Zhou,Jingxun Wu,Shiang Jiin Leaw,Jing Zhang,Xiao Lin,Liang Liang,Nong Yang |
| Citations | 404 |
| DOI | 10.1001/jamaoncol.2021.0366 |
| Fields | Medicine |
| Open Access | true |
| OA Status | hybrid |
| OA URL | https://jamanetwork.com/journals/jamaoncology/articlepdf/2777901/jamaoncology_wang_2021_oi_210004_1636496181.08904.pdf |
| OpenAlex ID | https://openalex.org/W3144903047 |
| PMID | 33792623 |
| Type | article |
| Year | 2021 |

## Paper authors

- [Nong Yang](https://scholariq.org/researchers/nong-yang/)

## Paper journal

- [JAMA Oncology](https://scholariq.org/journals/jama-oncology/)

## Paper primary topic

- [Cancer Immunotherapy and Biomarkers](https://scholariq.org/topics/cancer-immunotherapy-and-biomarkers/)

## Paper topics

- [Cancer Immunotherapy and Biomarkers](https://scholariq.org/topics/cancer-immunotherapy-and-biomarkers/)
- [Lung Cancer Treatments and Mutations](https://scholariq.org/topics/lung-cancer-treatments-and-mutations/)
- [Lung Cancer Diagnosis and Treatment](https://scholariq.org/topics/lung-cancer-diagnosis-and-treatment/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.